Loading...
Please wait, while we are loading the content...
Similar Documents
Vascular Access Port Systems and Methods
| Content Provider | The Lens |
|---|---|
| Abstract | In certain systems disclosed herein, one or more of a first vascular access port and a second vascular access port can be selected by a customer. Each of the first and second vascular access ports can be implanted subcutaneously within a patient, and each can include a base configured to be attached to a vessel, a body that extends away from the base, and a guidance passageway that extends through the body and the base and includes a funnel region. A maximum height defined by the base and body of the second vascular access port can be greater than a maximum height defined by the base and body of the first vascular access port. |
| Related Links | https://www.lens.org/images/patent/123-933-708-352-103/pdf/US_2020_B2_10773010_123-933-708-352-103.pdf |
| Language | English |
| Publisher Date | 2019-03-12 |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Patent |
| Jurisdiction | United States of America |
| Date Applied | 2015-05-18 |
| Agent | Pillsbury Winthrop Shaw Pittman Llp |
| Applicant | Advent Access Pte Ltd |
| Application No. | 201514715553 |
| Claim | A system from which one or more of a first vascular access port and a second vascular access port can be selected by a customer, the system comprising: the first vascular access port, which is configured to be implanted subcutaneously within a patient and comprises: a base configured to be attached to a vessel that is at a first depth within a patient; a body comprising a palpation projection that extends away from the base, the base and the palpation projection defining a first maximum height; and a guidance passageway that extends through the body and the base and comprises a funnel region that comprises an entry mouth of which at least a portion is spaced from the base, wherein the guidance passageway decreases in size from the entry mouth toward the base, wherein the guidance passageway defines an opening in a bottom surface of the base and wherein the palpation projection is disposed over the opening; and the second vascular access port, which is configured to be implanted subcutaneously within a patient and comprises: a base configured to be attached to a vessel that is at a second depth within a patient that is greater than the first depth; a body comprising a palpation projection that extends away from the base, the base and the palpation projection defining a second maximum height that is greater than the first maximum height; and a guidance passageway that extends through the body and the base and comprises a funnel region that comprises an entry mouth of which at least a portion is spaced from the base, wherein the guidance passageway decreases in size from the entry mouth toward the base, wherein the guidance passageway defines an opening in a bottom surface of the base and wherein the palpation projection is disposed over the opening. The system of claim 1 , wherein the first and second vascular access ports are configured to be implanted such that the palpation projection is from about 3 mm to about 6 mm beneath a skin surface. The system of claim 1 , wherein the palpation projections are configured to be palpated by a finger of a practitioner, wherein location and orientation of the first and second vascular access ports is defined. The system of claim 1 , wherein the first maximum height and the second maximum height ranges from about 2 mm to about 15 mm. The system of claim 1 , wherein the first and second vascular access ports are oriented in the same direction, wherein the entry mouths are distally directed following subcutaneous implantation of the first and second vascular access ports. The system of claim 1 , wherein the first and second vascular access ports are oriented in opposing directions following subcutaneous implantation of the first and second vascular access ports. |
| CPC Classification | Devices For Introducing Media Into; Or Onto; The Body ;Devices For Transducing Body Media Or For Taking Media From The Body ;Devices For Producing Or Ending Sleep Or Stupor Diagnosis; Surgery; Identification |
| Examiner | Laura A Bouchelle |
| Extended Family | 179-597-307-323-012 171-190-202-992-804 123-933-708-352-103 076-832-151-759-022 027-536-449-565-892 180-287-235-672-88X 051-076-010-390-171 107-000-502-301-138 104-426-702-255-69X 012-010-175-867-189 152-159-277-150-906 040-795-935-451-513 076-592-877-455-79X 048-113-475-706-625 141-616-951-341-969 055-622-138-563-976 141-093-580-750-922 015-775-925-907-260 022-191-127-928-627 090-828-895-663-918 077-382-313-735-746 074-095-643-173-976 077-514-543-820-358 021-441-908-699-524 112-523-973-815-34X 082-547-904-677-748 104-790-938-067-039 091-894-450-933-657 081-419-003-666-635 010-875-810-700-565 043-248-979-117-265 166-359-235-112-99X 155-741-893-460-636 175-545-289-029-804 069-276-691-766-276 166-421-374-893-751 161-995-984-244-450 013-952-047-425-613 |
| Patent ID | 10226564 |
| Inventor/Author | Young Nathaniel P Smith G Doug Crawford Mark A |
| IPC | A61M39/02 A61B17/00 A61B17/34 A61M1/14 A61M1/36 |
| Status | Active |
| Owner | Vital Access Corporation Advent Access Pte. Ltd |
| Simple Family | 123-933-708-352-103 171-190-202-992-804 179-597-307-323-012 027-536-449-565-892 180-287-235-672-88X 051-076-010-390-171 104-426-702-255-69X 012-010-175-867-189 040-795-935-451-513 152-159-277-150-906 076-592-877-455-79X 048-113-475-706-625 141-616-951-341-969 055-622-138-563-976 141-093-580-750-922 090-828-895-663-918 077-382-313-735-746 074-095-643-173-976 077-514-543-820-358 021-441-908-699-524 081-419-003-666-635 091-894-450-933-657 104-790-938-067-039 043-248-979-117-265 155-741-893-460-636 175-545-289-029-804 161-995-984-244-450 |
| CPC (with Group) | A61M1/3653 A61B17/0057 A61B17/3423 A61B2017/00654 A61B2017/3425 A61M1/3659 A61M1/3661 A61M39/0208 A61M2039/0223 A61M2039/0238 A61M2205/0238 A61B2017/00641 A61M1/14 A61M2039/0226 |
| Issuing Authority | United States Patent and Trademark Office (USPTO) |
| Kind | Patent/New European patent specification (amended specification after opposition procedure) |
